Tendia

Quick links to important sections

Tendia

Treatment option: Pain, Chronic Pain

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tendia

Understanding Tendia

Tendia is an oral medication categorized as a dipeptidyl peptidase-4 (DPP-4) inhibitor, commonly referred to as a gliptin. It is designed to assist in the management of glycemic levels in adults with type 2 diabetes mellitus.

Mechanism of Action

The primary function of Tendia is to regulate the levels of insulin and glucagon in the body. It works by inhibiting the DPP-4 enzyme, which is responsible for the breakdown of incretin hormones. These hormones, such as glucagon-like peptide-1 (GLP-1), are naturally released by the intestines throughout the day and their levels increase in response to a meal.

By preventing the degradation of these hormones, Tendia helps the body:

  • Increase insulin secretion: It stimulates the pancreas to produce more insulin when blood sugar levels are high.
  • Reduce glucagon production: It signals the liver to lower the production of glucose when it is not needed.

Role in Diabetes Management

In type 2 diabetes, the body may not produce enough insulin or may not use the insulin it produces effectively. This leads to elevated blood glucose levels. Tendia is used to improve blood sugar control specifically when diet and exercise alone do not provide sufficient management.

Unlike some other glucose-lowering medications, DPP-4 inhibitors like Tendia are glucose-dependent. This means they primarily act when blood sugar levels are elevated, which reduces the likelihood of blood sugar dropping too low during periods between meals. It is often used as a monotherapy or in combination with other glucose-lowering agents to achieve long-term glycemic targets.

Regulatory References

  1. Public Assessment Report (PAR) on Tramadol

What side effects are possible with Tendia?

Possible Side Effects and Safety Information

Tindia (Tramadol Hydrochloride) is associated with an official safety profile that defines possible adverse reactions by frequency and organ system, based on clinical trial data and regulatory oversight. The most frequently documented effects often involve the Gastrointestinal System and the Nervous System.


Frequency of Adverse Reactions

The following are classified as Very Common (occurring in ge 10% of patients) in official labeling: Nausea, Dizziness, Somnolence (Drowsiness), and Constipation. Reactions classified as Common (1% to <10%) include Vomiting, Headache, Pruritus (Itching), Sweating (Hyperhidrosis), and Dry Mouth.


Serious Adverse Reactions

Official regulatory documents highlight the potential for serious, life-threatening adverse reactions. The most significant risk is life-threatening respiratory depression, with the greatest risk occurring during the initiation of therapy or following a dose increase. Other serious documented risks include Seizures (Convulsions), Serotonin Syndrome (especially when used with other serotonergic medicines), and severe allergic responses such as Anaphylactoid Reactions.


Population-Specific Safety Constraints

The official labeling defines specific constraints for certain populations. Tindia is contraindicated in children younger than 12 years of age. It is also noted that physical dependence and withdrawal syndrome are risks associated with long-term use and that clearance of the medicine is significantly decreased in patients with severe renal or hepatic impairment.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation defines the overdose profile of Tendia (Tramadol Hydrochloride) by emphasizing several severe, life-threatening manifestations. The primary concern is life-threatening respiratory depression and progressive Central Nervous System (CNS) depression, which can advance to coma and circulatory failure.

Overdose manifestations also include neurological events such as seizures (convulsions), miosis, and symptoms consistent with Serotonin Syndrome, including hyperthermia and myoclonus. Accidental ingestion, particularly by children, carries a high risk of fatal overdose and requires immediate action.

Emergency Actions and Management

Action/Measure Official Regulatory Statement
Immediate Help Required Seek immediate medical attention for any suspected overdose or accidental ingestion.
Antidote Use Naloxone may be administered to reverse CNS and respiratory effects, but its use requires caution due to the documented risk of precipitating seizures.
Supportive Care Management is primarily symptomatic and supportive, often requiring ventilatory support and Intravenous Benzodiazepines for seizure control.

Official labels classify these events as life-threatening and potentially fatal. Treatment requires hospital monitoring, as procedures like haemodialysis are generally not effective for detoxification.

Therapeutic Uses of Tendia

The primary therapeutic purpose of Tendia is to provide support for pain management when symptoms become difficult to tolerate. Tendia is generally applied for pain categorized as moderate to moderately severe in intensity.


Targeting Moderate to Moderately Severe Pain

This medication is considered relevant for addressing symptoms related to physical discomfort in situations requiring supportive relief, such as pain following a surgical procedure or traumatic injury, and persistent pain associated with osteoarthritis or certain types of neuropathic pain. It is generally used for providing symptomatic relief for acute pain that has arisen suddenly, or for managing chronic discomfort that is persistent over time.

“It is used in therapeutic areas to help patients cope more steadily with symptom fluctuations and support general well-being during symptomatic phases.”

In these clinical settings that involve acute or unstable symptom patterns, Tendia provides supportive relief that helps ease the overall symptom burden. For patients with chronic conditions, its use may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Symptomatic Relief Focus: Moderate to Moderately Severe Pain

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Tindia (Tramadol Hydrochloride) is strictly defined by government regulatory documents, establishing absolute contraindications and population-specific restrictions. The medicine is generally approved for use in adults.

Contraindications and Prohibited Use

Use is contraindicated in several groups due to severe risks. This includes all children younger than 12 years of age and all patients under 18 for post-operative pain management following tonsillectomy or adenoidectomy. The medicine must not be used in patients with significant respiratory depression, uncontrolled epilepsy, or those experiencing acute intoxication by alcohol, opioids, or other central depressants. Patients taking Monoamine Oxidase Inhibitors (MAOIs), or who have taken them within the last 14 days, are strictly prohibited from using this medicine.

Restricted and Conditional Use

Eligibility is restricted for populations with altered drug clearance. For patients with severe renal impairment (creatinine clearance < 30 mL/min) or severe hepatic impairment, use is generally not recommended or requires strict limitation. Use is not recommended for women who are pregnant (due to the risk of Neonatal Opioid Withdrawal Syndrome) or for those who are breastfeeding.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documents require attention to specific drug-drug interactions, which may necessitate dose adjustments or the selection of alternative therapies.

Significant Interaction Categories

The following categories of medicinal products have documented interactions:

  • Other Antidiabetic Agents: Medications such as insulin and sulfonylureas (e.g., glipizide) are known to increase the risk of hypoglycemia (low blood sugar) when co-administered with this drug. Regulatory labeling specifies that a lower dose of the insulin secretagogue or insulin may be required to manage this risk.
  • Strong Inducers of P-glycoprotein (P-gp) and Cytochrome P450 3A4 (CYP3A4): Co-administration with strong inducers, such as rifampin, can lead to a clinically significant reduction in this drug's plasma concentration and therapeutic efficacy. Authorities strongly recommend using an alternative treatment that does not induce P-gp or CYP3A4 to avoid treatment failure.

Specific Interaction Constraints

The most important constraints are tied to the resulting clinical outcome:

  1. Reduced Efficacy Constraint: Use with strong P-gp/CYP3A4 inducers is generally discouraged due to the documented reduction in the drug's effectiveness.
  2. Hypoglycemia Risk Constraint: Use with insulin or sulfonylureas requires a mandatory assessment and potential adjustment of the concomitant therapy's dosage to mitigate the heightened risk of hypoglycemia.

Mechanism of Action

How Tendia Works

Tendia's mechanism relies on a unique dual action within the central nervous system to modulate the transmission of nociceptive signals.

Direct Modulation of mu-Opioid Receptors

This core mechanistic domain involves the activation of the mu-Opioid Receptor (MOP) by the active metabolite, O-Desmethyltramadol (M1). Activation of these receptors initiates a cellular cascade that causes the nerve cells to hyperpolarize, physically suppressing their ability to release key signaling neurotransmitters. This results in the direct suppression of ascending nociceptive signal transmission at the spinal cord level. This domain provides a direct mechanism to suppress transmission by modulating hyperactive nociceptive signaling patterns.

Enhancement of Descending Monoaminergic Modulation

The second mechanism, mediated by the parent drug, involves the weak inhibition of Norepinephrine and Serotonin reuptake. By increasing the concentration of these neurotransmitters in the synaptic cleft, the drug strengthens the function of the Descending Nociceptive Inhibitory Pathway (DNIC). This complements the direct opioid effect by reinforcing the descending inhibitory pathways, leading to enhanced modulation of afferent nociceptive signals.

Constraint by Metabolic Activation

The full functional output of the opioid component is inherently linked to the metabolic conversion of the parent drug to the M1 metabolite by the CYP2D6 enzyme. Variability in CYP2D6 activity can functionally constrain the output of the MOP agonism, demonstrating how a molecular step determines the maximum mechanistic action. The resulting physiological state is characterized by a decreased output of central nociceptive signal transmission.

Dosage and Administration Information

How Tendia is Used: Official Administration Guidelines

Tendia (Tramadol Hydrochloride) is officially approved for use via both oral and parenteral routes. The oral forms include immediate-release (IR) tablets, capsules, and solutions, while the parenteral route covers intravenous (IV), intramuscular (IM), and subcutaneous (SC) injection.

Dosing is dependent upon the specific formulation. For immediate-release forms, the standard adult dose is typically 50 mg to 100 mg, administered every 4 to 6 hours as needed, with the daily maximum dose not to exceed 400 mg. These IR forms may be taken without regard to food. In contrast, the extended-release forms are generally initiated at 100 mg and are taken once daily for continuous relief.

A critical administration requirement is that ER tablets and capsules must be swallowed whole and must not be crushed, split, chewed, or dissolved. Official guidelines mandate adjustments for specific populations. For patients with severe renal impairment (CLcr < 30 mL/min), the IR dosing interval must be extended to 12 hours, with the daily maximum dose limited to 200 mg. After long-term use, the medication must be tapered gradually upon discontinuation to manage dependency.

Recent Clinical Evidence

Research evidence / Overview of studies for Tendia


Evidence for use in Pain Conditions

The research on Tendia's active ingredient, Tramadol, involves short-term Randomized Controlled Trials (RCTs) across both persistent (chronic) and sudden (acute) pain conditions. In chronic pain related to osteoarthritis or neuropathic states, studies involved adult patients with moderate to moderately severe pain, monitoring outcomes like changes in pain intensity scores and assessments of daily functioning. In acute pain settings, such as post-operative pain, research focused on very short-term measurements, typically tracking changes in pain and the need for rescue medication over the first 24 to 72 hours. Trials reported measurements of change in pain scores against placebo and active control comparators. The evidence available for acute pain has been characterized in research as having moderate certainty, while certainty for chronic pain outcomes remains lower.


Evidence in Special Populations

Specific research has been conducted for older adults, monitoring outcomes related to daily functioning. However, data for certain groups remain insufficient, particularly for patients with specific comorbidities. Official scientific literature notes that use in children and adolescents is subject to specific regulatory constraints and warnings due to limited research and safety considerations. The results of existing, limited trials apply only to the populations studied.


Evidence Gaps and Long-Term Uncertainty

Most high-quality RCTs have been conducted over short intervals (a few weeks to 16 weeks). Consequently, long-term effects are not fully established, and there is limited information regarding sustained pain relief or functional status beyond the initial study periods. This represents a key research limitation. Furthermore, analyses indicate that evidence quality varies across studies, and findings were often mixed or showed only small differences in measured outcomes compared to placebo in some analyses. Comparative evidence is lacking against all potential alternative treatments, highlighting areas where additional research is needed.

Frequently Asked Questions (FAQ)

Common questions about Tendia (FAQ)

Q: Will Tendia cure the condition it treats?

According to official classification, the primary therapeutic purpose of this medication is the relief of moderate to moderately severe pain. This means the drug helps manage symptoms rather than providing a cure for the underlying medical condition.

Q: How is Tendia different from other treatments for the same condition?

Regulatory texts describe this drug as having a dual mechanism of action, meaning it works in two distinct ways in the body. This combination—acting on mu-opioid receptors and blocking the reuptake of two key brain chemicals—is a distinguishing feature from some traditional pain relievers.

Q: Why is Tendia sometimes preferred over similar drugs?

This drug is categorized as a Schedule IV controlled substance by regulatory bodies. This classification indicates that it has a lower potential for abuse and dependence compared to drugs in more restricted categories, which can influence prescribing considerations.

Q: Can Tendia affect sleep patterns?

Official labeling lists Somnolence, which means drowsiness or feeling sleepy, as a very common adverse reaction. Because this drug affects wakefulness, official information indicates it can indirectly influence sleep patterns.

Q: Is it safe to drive while taking Tendia?

Regulatory safety information indicates that because of the potential for adverse effects such as dizziness and drowsiness (somnolence), activities requiring mental alertness, such as driving or operating hazardous machinery, are generally restricted until the effects of the medication are known. Understanding the medication's effects is necessary before engaging in activities that require full attention.

Q: Is Tendia safe for people with diabetes?

Studies and regulatory warnings indicate a potential risk of hypoglycemia (low blood sugar). This may occur even in diabetic patients not taking specific interacting medications. For this reason, blood glucose monitoring is noted as a potential component of management when using this drug.

Q: Is the research evidence for Tendia considered strong by regulators?

Regulatory overviews note that the certainty of evidence for the drug's effectiveness varies. Evidence for sudden (acute) pain is often characterized as having moderate certainty, while certainty for persistent (chronic) pain outcomes remains lower. Most high-quality trials have been conducted over short intervals (a few weeks).

Q: Do I need to take Tendia with food?

Official prescribing information states that the immediate-release forms of the medicine may be taken without regard to food. For specific concerns regarding administration or side effects, regulatory guidance advises speaking to a healthcare professional.

Q: Are there any known issues with suddenly stopping Tendia?

Regulatory guidance states that abrupt or rapid discontinuation in physically dependent patients is associated with serious withdrawal symptoms, uncontrolled pain, and other issues. Official guidance states that discontinuation must involve a gradual tapering process.

Q: How quickly should I expect to notice any effects from Tendia?

The official pharmacokinetics data indicates that the analgesic effects of the immediate-release form typically begin in less than one hour after oral administration. The peak effect usually occurs within two to four hours after taking the dose.

Q: What happens if I forget to take a dose of Tendia?

Regulatory instructions for a missed dose advise taking the next scheduled dose at the usual time. Regulatory instructions note that the dose should not be changed, and extra medicine should not be taken to compensate for a missed dose.

Q: Can I take Tendia with over-the-counter cold medicine?

The co-administration of this drug with certain over-the-counter cold medicines that contain ingredients like dextromethorphan is associated with an increased risk of a serious condition called Serotonin Syndrome, which is an officially documented safety concern.

Q: Are there any vitamins or supplements that interact with Tendia?

Official information advises patients to tell their doctor about all other medications, including vitamins and herbs. This is a necessary step to screen for any potential interactions that could affect the drug's safety or how well it works.

Q: Is it possible for Tendia to stop working over time?

Official clinical documents note that if a patient experiences inadequate pain control, the prescribing professional should consider the possibility of hyperalgesia (increased sensitivity to pain) or tolerance. Tolerance is a state where the body needs a consistent or increasing dose to achieve the same effect.

Q: Can Tendia change the results of blood tests?

The drug or its metabolites can potentially cause misidentification or interference with certain specialized laboratory drug screening tests, such as those for illicit drugs. It is generally necessary to disclose the use of this medication to testing personnel to ensure accurate interpretation of results.

Q: Is there a generic version of Tendia available?

The active component of this medication, Tramadol, is widely available in generic versions as well as brand name formulations. Generic medications contain the same active ingredient and are subject to the same strict quality standards as the brand-name product.

Q: Are there specific times of day Tendia is usually taken?

The dosing regimen depends on the type of formulation. Immediate-release forms are associated with an 'as needed' regimen based on a specified time interval, while extended-release forms are generally taken once daily for continuous pain relief.

Q: Why is my doctor asking about my other medications before prescribing Tendia?

The doctor needs to screen for interactions, as required by official safety guidelines. Certain co-administered drugs can increase the risk of serious adverse reactions, such as Serotonin Syndrome, or lead to reduced drug efficacy.

Q: Does Tendia require regular monitoring by a doctor?

Yes, official guidance recommends that if long-term treatment with this medicine is necessary, careful and regular monitoring should be carried out. This is done to establish whether continued treatment is appropriate.

Q: What should I do if the side effects of Tendia bother me?

Official patient guidance indicates that individuals should contact their healthcare provider if they experience bothersome side effects, increased pain, withdrawal symptoms, or any concerns about the medication. This allows for clinical assessment and management.

How should Tendia be stored and disposed of?

How to Store and Dispose of TENDIA (Tramadol Hydrochloride)

Official Storage Requirements

Tendia must be stored at room temperature, typically below 30 C (86°F), and protected from light and excess heat.

Containers must be kept tightly closed in the original packaging. Due to the risk of fatal overdose, the medicine must be stored locked up and kept out of the sight and reach of children.

Handling Note: Extended-release tablets and capsules must not be crushed, chewed, or dissolved to prevent the rapid release of a potentially fatal dose.

Disposal Instructions

Unused or expired Tendia should be disposed of using an authorized drug take-back program or mail-back envelope. If these options are unavailable, the medication should be mixed with an undesirable substance (like kitty litter or dirt), placed in a sealed container, and then discarded in the household trash. Tramadol is not on the list of medicines recommended for flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tendia found in:

A-Z Index: